Literature DB >> 7539627

Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor.

N J Bishop1, D M Williams, J C Compston, D M Stirling, A Prentice.   

Abstract

Recombinant human granulocyte colony-stimulating factor (G-CSF) has substantially improved life expectancy for children with severe congenital neutropenia (SCN). Severe osteoporosis, reported in this population, may relate to the disease process, or be a therapeutic side-effect. This report details bone loss, quantitated absorptiometrically and histomorphometrically, in a child with SCN and vertebral collapse, and the positive response to anabolic steroid and bisphosphonate therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539627     DOI: 10.1111/j.1365-2141.1995.tb08441.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

Review 1.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 2.  Biphosphonates.

Authors:  J Allgrove
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

3.  Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner.

Authors:  Angela C Hirbe; Ozge Uluçkan; Elizabeth A Morgan; Mark C Eagleton; Julie L Prior; David Piwnica-Worms; Kathryn Trinkaus; Anthony Apicelli; Katherine Weilbaecher
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

4.  Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis.

Authors:  Ralph Melchior; Bernard Zabel; Jürgen Spranger; Roland Schumacher
Journal:  Eur J Pediatr       Date:  2004-10-23       Impact factor: 3.183

5.  Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.

Authors:  A Matayoshi; C Brown; J F DiPersio; J Haug; Y Abu-Amer; H Liapis; R Kuestner; R Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 6.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

7.  Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization.

Authors:  Tsutomu Watanabe; Hiroko Suzuya; Toshihiro Onishi; Sachiyo Kanai; Michiya Kaneko; Hiroyoshi Watanabe; Ryuji Nakagawa; Yoshifumi Kawano; Yoichi Takaue; Yasuhiro Kuroda; James E Talmadge
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

Review 8.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

9.  The effects of short-term use of granulocyte colony-stimulating factor on bone metabolism in child cancer patients.

Authors:  Ayse Bozkurt Turhan; Cigdem Binay; Ozcan Bor; Enver Simsek
Journal:  North Clin Istanb       Date:  2018-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.